{"id":53,"date":"2017-06-16T15:30:42","date_gmt":"2017-06-16T14:30:42","guid":{"rendered":"http:\/\/www.mcns.scot.nhs.uk\/spah\/?page_id=53"},"modified":"2025-12-11T11:13:53","modified_gmt":"2025-12-11T11:13:53","slug":"protocolsguidance-group-paediatric","status":"publish","type":"page","link":"https:\/\/www.nn.nhs.scot\/spah\/professional-zone\/protocolsguidance-group-paediatric\/","title":{"rendered":"Paediatric Protocols\/Guidance"},"content":{"rendered":"\n<h2 class=\"wp-block-heading\">Acute Guidance<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><a href=\"https:\/\/www.spah.scot.nhs.uk\/wp-content\/uploads\/sites\/5\/2023\/06\/NSD610-017.01-The-Management-of-Acute-A...-Pain-in-children-with-Sickle-Cell-2.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">Acute abdominal pain in children with Sickle Cell disease<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/www.spah.scot.nhs.uk\/wp-content\/uploads\/sites\/5\/2023\/10\/NSD610-017.02-SPAH-Paediatric-Sickle-Cell-Disease-Acute-Anaemia-1.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">Acute Anaemia<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/www.spah.scot.nhs.uk\/wp-content\/uploads\/sites\/5\/2023\/02\/NSD610-017.33-SPAH-Acute-Chest-Syndrome-Paediatric-Guideline.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">Acute Chest Syndrome<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/www.nn.nhs.scot\/spah\/wp-content\/uploads\/sites\/5\/2025\/06\/NSD610-017.15-SPAH-paed-Chronic-Transfusion-in-Thal-guideline-v1-final.pdf\">Chronic Transfusion in Thalassaemia<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/www.nn.nhs.scot\/spah\/wp-content\/uploads\/sites\/5\/2024\/04\/NSD610-017.16-SPAH-Monitoring-and-management-of-Endocrine-complications-in-children-with-TDT.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">Monitoring and management of endocrine complications in children with transfusion dependent thalassemia (TDT)<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/www.nn.nhs.scot\/spah\/wp-content\/uploads\/sites\/5\/2024\/04\/NSD610-017.16-SPAH-Monitoring-and-management-of-Endocrine-complications-in-children-with-TDT.pdf\">Endocrine complications in children with Thalassaemia<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/www.spah.scot.nhs.uk\/wp-content\/uploads\/sites\/5\/2021\/08\/Exchange-transfusion.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">Exchange Transfusion<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/www.spah.scot.nhs.uk\/wp-content\/uploads\/sites\/5\/2023\/06\/NSD610-017.06-SPAH-Use-of-Hydroxycarbamide-in-paediatric-Sickle-Cell-Disease.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">Hydroxycarbamide in Sickle Cell disease<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/www.spah.scot.nhs.uk\/wp-content\/uploads\/sites\/5\/2022\/11\/NSD-610-017.25-Inpatient-Specialist-Mgt.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">Inpatient Specialist Management of acutely unwell children with haemoglobinopathies<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/www.spah.scot.nhs.uk\/wp-content\/uploads\/sites\/5\/2023\/02\/NSD610-017.07-SPAH-Iron-overload-and-chelation-therapy.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">Iron overload and chelation therapy<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/www.spah.scot.nhs.uk\/wp-content\/uploads\/sites\/5\/2022\/12\/NSD610-017.19-Management-of-Hyperhaemolysis-in-patients-with-Sickle-Cell-Disease-1.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">Management of Hyperhaemolysis in patients with Sickle Cell disease<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/www.nn.nhs.scot\/spah\/wp-content\/uploads\/sites\/5\/2024\/11\/NSD610-017.10-SPAH-Paed-Priapism-guideline.pdf\">Management of Priapism in Sickle Cell disease<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/www.spah.scot.nhs.uk\/wp-content\/uploads\/sites\/5\/2022\/09\/NSD610-017-08-Painful-Sickle-Cell-Crisis.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">Painful Sickle Cell crisis (management)<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/www.nn.nhs.scot\/spah\/wp-content\/uploads\/sites\/5\/2025\/05\/NSD610-017.23-SPAH-Physiotherapy-guideline-acute-management-SCD.pdf\" data-type=\"link\" data-id=\"https:\/\/www.nn.nhs.scot\/spah\/wp-content\/uploads\/sites\/5\/2025\/05\/NSD610-017.23-SPAH-Physiotherapy-guideline-acute-management-SCD.pdf\">Physiotherapy guideline for the acute management of paediatric &amp; adult patients with Sickle Cell disease<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/www.spah.scot.nhs.uk\/wp-content\/uploads\/sites\/5\/2021\/10\/Stem-Cell-Transplant.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">Stem Cell Transplant<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/www.spah.scot.nhs.uk\/wp-content\/uploads\/sites\/5\/2022\/11\/NSD610-017.50-SPAH-Paediatric-Guideline-Stroke-and-Other-CNS-Manifestations-in-Sickle-Cell-Disease.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">Stroke and other CNS manifestations<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/www.spah.scot.nhs.uk\/wp-content\/uploads\/sites\/5\/2023\/11\/NSD610-017.30-SPAH-Surgery-Anaesthesia.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">Surgery and Anaesthesia<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/www.nn.nhs.scot\/spah\/wp-content\/uploads\/sites\/5\/2024\/04\/NSD610-017.20-SPAH-Transcranial-Doppler-TCD-screening-for-Sickle-Cell-Disease-SCD.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">Transcranial Doppler (TCD) screening for Sickle Cell disease<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/www.nn.nhs.scot\/spah\/wp-content\/uploads\/sites\/5\/2023\/06\/NSD610-017.55-SPAH-\u2013-Diagnosis-and-Management-of-Non-Transfusion-Dependent-Thalassaemia-NTDT-phenotypes-1.pdf\" data-type=\"link\" data-id=\"https:\/\/www.nn.nhs.scot\/spah\/wp-content\/uploads\/sites\/5\/2023\/06\/NSD610-017.55-SPAH-\u2013-Diagnosis-and-Management-of-Non-Transfusion-Dependent-Thalassaemia-NTDT-phenotypes-1.pdf\">Diagnosis and Management of Non-Transfusion-Dependent Thalassaemia (NTDT) phenotypes<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/www.nn.nhs.scot\/spah\/wp-content\/uploads\/sites\/5\/2025\/06\/NSD610-017.65-SPAH-Vaccination-guideline-v1.pdf\" data-type=\"link\" data-id=\"https:\/\/www.nn.nhs.scot\/spah\/wp-content\/uploads\/sites\/5\/2025\/06\/NSD610-017.65-SPAH-Vaccination-guideline-v1.pdf\">Vaccination<\/a><\/li>\n<\/ul>\n\n\n\n<p>Guidance due for review is being considered by the SPAH Guidance subgroups.\u00a0 Information contained within the guidance has been approved to remain in the website.<\/p>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p class=\"nhsuk-card__description\">Guidance to support paediatric clinicians in the care of a patient with an haemoglobinopathy.<\/p>\n","protected":false},"author":4,"featured_media":0,"parent":8,"menu_order":1,"comment_status":"closed","ping_status":"closed","template":"subpage-promo-blocks-with-sidebar.php","meta":{"footnotes":""},"class_list":["post-53","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/www.nn.nhs.scot\/spah\/wp-json\/wp\/v2\/pages\/53","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.nn.nhs.scot\/spah\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.nn.nhs.scot\/spah\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.nn.nhs.scot\/spah\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.nn.nhs.scot\/spah\/wp-json\/wp\/v2\/comments?post=53"}],"version-history":[{"count":181,"href":"https:\/\/www.nn.nhs.scot\/spah\/wp-json\/wp\/v2\/pages\/53\/revisions"}],"predecessor-version":[{"id":3527,"href":"https:\/\/www.nn.nhs.scot\/spah\/wp-json\/wp\/v2\/pages\/53\/revisions\/3527"}],"up":[{"embeddable":true,"href":"https:\/\/www.nn.nhs.scot\/spah\/wp-json\/wp\/v2\/pages\/8"}],"wp:attachment":[{"href":"https:\/\/www.nn.nhs.scot\/spah\/wp-json\/wp\/v2\/media?parent=53"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}